267 related articles for article (PubMed ID: 29445378)
21. Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens.
Wuhrer M; Porcelijn L; Kapur R; Koeleman CA; Deelder A; de Haas M; Vidarsson G
J Proteome Res; 2009 Feb; 8(2):450-6. PubMed ID: 18942870
[TBL] [Abstract][Full Text] [Related]
22. Immunoglobulin G Subclass-Specific Glycosylation Changes in Primary Epithelial Ovarian Cancer.
Wieczorek M; Braicu EI; Oliveira-Ferrer L; Sehouli J; Blanchard V
Front Immunol; 2020; 11():654. PubMed ID: 32477323
[TBL] [Abstract][Full Text] [Related]
23. Functional interactions of red cells sensitized by IgG1 and IgG3 human monoclonal anti-D with enzyme-modified human monocytes and FcR-bearing cell lines.
Kumpel BM; Hadley AG
Mol Immunol; 1990 Mar; 27(3):247-56. PubMed ID: 2111455
[TBL] [Abstract][Full Text] [Related]
24. Different glycosylation pattern of human IgG1 and IgG3 antibodies isolated from transiently as well as permanently transfected cell lines.
Vestrheim AC; Moen A; Egge-Jacobsen W; Bratlie DB; Michaelsen TE
Scand J Immunol; 2013 May; 77(5):419-28. PubMed ID: 23488770
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic anti-D preparations display variable decreases in Fc-fucosylation of anti-D.
Kapur R; Della Valle L; Verhagen OJ; Hipgrave Ederveen A; Ligthart P; de Haas M; Kumpel B; Wuhrer M; van der Schoot CE; Vidarsson G
Transfusion; 2015 Mar; 55(3):553-62. PubMed ID: 25234110
[TBL] [Abstract][Full Text] [Related]
26. Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities.
Dekkers G; Treffers L; Plomp R; Bentlage AEH; de Boer M; Koeleman CAM; Lissenberg-Thunnissen SN; Visser R; Brouwer M; Mok JY; Matlung H; van den Berg TK; van Esch WJE; Kuijpers TW; Wouters D; Rispens T; Wuhrer M; Vidarsson G
Front Immunol; 2017; 8():877. PubMed ID: 28824618
[TBL] [Abstract][Full Text] [Related]
27. Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn.
Kapur R; Della Valle L; Sonneveld M; Hipgrave Ederveen A; Visser R; Ligthart P; de Haas M; Wuhrer M; van der Schoot CE; Vidarsson G
Br J Haematol; 2014 Sep; 166(6):936-45. PubMed ID: 24909983
[TBL] [Abstract][Full Text] [Related]
28. Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes.
Bredius RG; Fijen CA; De Haas M; Kuijper EJ; Weening RS; Van de Winkel JG; Out TA
Immunology; 1994 Dec; 83(4):624-30. PubMed ID: 7875742
[TBL] [Abstract][Full Text] [Related]
29. Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid.
Scherer HU; van der Woude D; Ioan-Facsinay A; el Bannoudi H; Trouw LA; Wang J; Häupl T; Burmester GR; Deelder AM; Huizinga TW; Wuhrer M; Toes RE
Arthritis Rheum; 2010 Jun; 62(6):1620-9. PubMed ID: 20178128
[TBL] [Abstract][Full Text] [Related]
30. Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitis.
Culver EL; van de Bovenkamp FS; Derksen NIL; Koers J; Cargill T; Barnes E; de Neef LA; Koeleman CAM; Aalberse RC; Wuhrer M; Rispens T
J Gastroenterol Hepatol; 2019 Oct; 34(10):1878-1886. PubMed ID: 30345709
[TBL] [Abstract][Full Text] [Related]
31. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.
Kumpel BM; Rademacher TW; Rook GA; Williams PJ; Wilson IB
Hum Antibodies Hybridomas; 1994; 5(3-4):143-51. PubMed ID: 7756579
[TBL] [Abstract][Full Text] [Related]
32. Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.
Wuhrer M; Selman MH; McDonnell LA; Kümpfel T; Derfuss T; Khademi M; Olsson T; Hohlfeld R; Meinl E; Krumbholz M
J Neuroinflammation; 2015 Dec; 12():235. PubMed ID: 26683050
[TBL] [Abstract][Full Text] [Related]
33. Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis.
Kemna MJ; Plomp R; van Paassen P; Koeleman CAM; Jansen BC; Damoiseaux JGMC; Cohen Tervaert JW; Wuhrer M
EBioMedicine; 2017 Mar; 17():108-118. PubMed ID: 28169190
[TBL] [Abstract][Full Text] [Related]
34. The Biology of IgG Subclasses and Their Clinical Relevance to Transplantation.
Valenzuela NM; Schaub S
Transplantation; 2018 Jan; 102(1S Suppl 1):S7-S13. PubMed ID: 29266057
[TBL] [Abstract][Full Text] [Related]
35. IgG1 and IgG3 anti-D in maternal serum and on the RBCs of infants suffering from HDN: relationship with the severity of the disease.
Lambin P; Debbia M; Puillandre P; Brossard Y
Transfusion; 2002 Dec; 42(12):1537-46. PubMed ID: 12473131
[TBL] [Abstract][Full Text] [Related]
36. A new Fc receptor on mouse macrophages binding IgG3.
Diamond B; Yelton DE
J Exp Med; 1981 Mar; 153(3):514-9. PubMed ID: 7252406
[TBL] [Abstract][Full Text] [Related]
37. IgG1 Fc N-glycan galactosylation as a biomarker for immune activation.
de Jong SE; Selman MH; Adegnika AA; Amoah AS; van Riet E; Kruize YC; Raynes JG; Rodriguez A; Boakye D; von Mutius E; Knulst AC; Genuneit J; Cooper PJ; Hokke CH; Wuhrer M; Yazdanbakhsh M
Sci Rep; 2016 Jun; 6():28207. PubMed ID: 27306703
[TBL] [Abstract][Full Text] [Related]
38. ADCC (K-cell) lysis of human erythrocytes sensitized with rhesus alloantibodies. III. Comparison of IgG anti-D agglutinating and lytic (ADCC) activity and the role of IgG subclasses.
Urbaniak SJ; Greiss MA
Br J Haematol; 1980 Nov; 46(3):447-53. PubMed ID: 6778497
[TBL] [Abstract][Full Text] [Related]
39. Associations between an IgG3 polymorphism in the binding domain for FcRn, transplacental transfer of malaria-specific IgG3, and protection against Plasmodium falciparum malaria during infancy: A birth cohort study in Benin.
Dechavanne C; Dechavanne S; Sadissou I; Lokossou AG; Alvarado F; Dambrun M; Moutairou K; Courtin D; Nuel G; Garcia A; Migot-Nabias F; King CL
PLoS Med; 2017 Oct; 14(10):e1002403. PubMed ID: 28991911
[TBL] [Abstract][Full Text] [Related]
40. IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.
Fokkink WJ; Selman MH; Dortland JR; Durmuş B; Kuitwaard K; Huizinga R; van Rijs W; Tio-Gillen AP; van Doorn PA; Deelder AM; Wuhrer M; Jacobs BC
J Proteome Res; 2014 Mar; 13(3):1722-30. PubMed ID: 24533874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
